Bortezomib Does Not Prevent the Occurrence of Kaposi’s Sarcoma in Patients with Haematological Malignancies: Two Case Reports

by Nathalie Chavarot, Celeste Lebbe, Eric Thervet, Didier Bouscary, Alexandre Karras
Published 2017-06-01

Case Report: Clinical Experience With Avelumab in Patients With Metastatic Merkel Cell Carcinoma and Brain Metastases Treated in Europe

by Kate Fife, Pauline Tétu, Jessica Prabhakaran, Celeste Lebbé, Giovanni Grignani
Published 2021-05-01

Atypical <i>BRAF</i> and <i>NRAS</i> Mutations in Mucosal Melanoma

by Nicolas Dumaz, Fanélie Jouenne, Julie Delyon, Samia Mourah, Armand Bensussan, Céleste Lebbé
Published 2019-08-01

Sebaceous Carcinomas of the Skin: 24 Cases and a Literature Review

by Roger Haber, Maxime Battistella, Cecile Pages, Martine Bagot, Celeste Lebbe, Nicole Basset-Seguin
Published 2017-05-01

New Vision in Photoprotection and Photorepair

by Marie-Therese Leccia, Celeste Lebbe, Jean-Paul Claudel, Mridvika Narda, Nicole Basset-Seguin
Published 2019-01-01

CD147 Is a Promising Target of Tumor Progression and a Prognostic Biomarker

by Alexandra Landras, Coralie Reger de Moura, Fanelie Jouenne, Celeste Lebbe, Suzanne Menashi, Samia Mourah
Published 2019-11-01

Discoidin Domain Receptors in Melanoma: Potential Therapeutic Targets to Overcome MAPK Inhibitor Resistance

by Coralie Reger de Moura, Coralie Reger de Moura, Marco Prunotto, Anjum Sohail, Maxime Battistella, Maxime Battistella, Fanelie Jouenne, Fanelie Jouenne, Daniel Marbach, Celeste Lebbé, Celeste Lebbé, Rafael Fridman, Samia Mourah, Samia Mourah
Published 2020-09-01

Locally Aggressive Trichoblastic Tumours (Low-grade Trichoblastic Carcinomas): Clinicopathological Analysis and Follow-up

by Camille Hua, Charles Velter, Amelie Osio, Céleste Lebbe, Nicole Basset-Seguin, Bernard Cribier, Maxime Battistella
Published 2017-09-01

A reliable method for the selection of exploitable melanoma archival paraffin embedded tissues for transcript biomarker profiling.

by Celeste Lebbe, Mickael Guedj, Nicole Basset-Seguin, Marie Pierre Podgorniak, Suzanne Menashi, Anne Janin, Samia Mourah
Published 2012-01-01

Human Herpesvirus 8 (HHV8) sequentially shapes the NK cell repertoire during the course of asymptomatic infection and Kaposi sarcoma.

by Stéphanie Dupuy, Marion Lambert, David Zucman, Siméon-Pierre Choukem, Sara Tognarelli, Cécile Pages, Céleste Lebbé, Sophie Caillat-Zucman
Published 2012-01-01

Epidemiology of Cutaneous T-Cell Lymphomas: A Systematic Review and Meta-Analysis of 16,953 Patients

by Gabor Dobos, Anne Pohrt, Caroline Ram-Wolff, Céleste Lebbé, Jean-David Bouaziz, Maxime Battistella, Martine Bagot, Adèle de Masson
Published 2020-10-01

Lack of evidence for the involvement of Merkel cell polyomavirus in pulmonary Langerhans cell histiocytosis

by Fanélie Jouenne, Jérôme Le Goff, Emmanuelle Bugnet, Maud Salmona, Véronique Meignin, Gwenaël Lorillon, Aurélie Sadoux, Janine Cherot, Céleste Lebbé, Samia Mourah, Abdellatif Tazi
Published 2020-05-01

EMMPRIN promotes melanoma cells malignant properties through a HIF-2alpha mediated up-regulation of VEGF-receptor-2.

by Faten Bougatef, Suzanne Menashi, Farah Khayati, Benyoussef Naïmi, Raphaël Porcher, Marie-Pierre Podgorniak, Guy Millot, Anne Janin, Fabien Calvo, Céleste Lebbé, Samia Mourah
Published 2010-08-01

FGF2 Induces Resistance to Nilotinib through MAPK Pathway Activation in KIT Mutated Melanoma

by Pauline Tétu, Julie Delyon, Jocelyne André, Coralie Reger de Moura, Malak Sabbah, Ghanem E Ghanem, Maxime Battistella, Samia Mourah, Céleste Lebbé, Nicolas Dumaz
Published 2020-04-01

Systemic Treatment Initiation in Classical and Endemic Kaposi’s Sarcoma: Risk Factors and Global Multi-State Modelling in a Monocentric Cohort Study

by Lina Benajiba, Jérôme Lambert, Roberta La Selva, Delphine Cochereau, Barouyr Baroudjian, Jennifer Roux, Jérôme Le Goff, Cécile Pages, Maxime Battistella, Julie Delyon, Céleste Lebbé
Published 2021-05-01

Impact of New Systemic Treatment and Radiotherapy in Melanoma Patients with Leptomeningeal Metastases

by Pauline Tétu, Lila Sirven-Villaros, Stefania Cuzzubbo, Renata Ursu, Barouyr Baroudjian, Julie Delyon, François Nataf, Constance De Margerie-Mellon, Clara Allayous, Wendy Lefevre, Antoine F. Carpentier, Céleste Lebbé
Published 2020-09-01

Baseline Genomic Features in <i>BRAFV600</i>-Mutated Metastatic Melanoma Patients Treated with BRAF Inhibitor + MEK Inhibitor in Routine Care

by Baptiste Louveau, Fanelie Jouenne, Coralie Reger de Moura, Aurelie Sadoux, Barouyr Baroudjian, Julie Delyon, Florian Herms, Adele De Masson, Laetitia Da Meda, Maxime Battistella, Nicolas Dumaz, Celeste Lebbe, Samia Mourah
Published 2019-08-01

Intermittent Versus Continuous Dosing of MAPK Inhibitors in the Treatment of BRAF-Mutated Melanoma

by Coralie Reger de Moura, Laetitia Vercellino, Fanélie Jouenne, Barouyr Baroudjian, Aurélie Sadoux, Baptiste Louveau, Julie Delyon, Kevin Serror, Lauriane Goldwirt, Pascal Merlet, Fanny Bouquet, Maxime Battistella, Céleste Lebbé, Samia Mourah
Published 2020-02-01

Mechanisms Underpinning Increased Plasma Creatinine Levels in Patients Receiving Vemurafenib for Advanced Melanoma.

by Charlotte Hurabielle, Evangéline Pillebout, Thomas Stehlé, Cécile Pagès, Jennifer Roux, Pierre Schneider, Sylvie Chevret, Cendrine Chaffaut, Anne Boutten, Samia Mourah, Nicole Basset-Seguin, Emmanuelle Vidal-Petiot, Céleste Lebbé, Martin Flamant
Published 2016-01-01

433 Talimogene laherparepvec (T-VEC) in combination with ipilimumab (IPI) versus IPI alone for advanced melanoma: 4-year interim analysis of a randomized, open-label, phase 2 trial...

by Min Yi, Celeste Lebbe, Parminder Singh, Omid Hamid, Jason Chesney, Igor Puzanov, Mohammed Milhem, Merrick Ross, Janice Mehnert, Theodore Logan, Philip Friedlander, Frances Collichio, Claus Garbe, John Glaspy, Axel Hauschild, Wendy Snyder
Published 2020-11-01